Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Alzheimer's Disease

In brief

This study will investigate the ability of ST101 to improve memory in people with Alzheimer's disease. This study also will examine the safety and tolerability of the drug. This study is evaluating 3 different dose levels of ST101 and placebo. Patients will have a 1 in 4 chance of getting placebo.

Key facts

Study ID

NCT00842673

Run by

Sonexa Therapeutics, Inc.

People needed

168

Starts

2009-02-01

Expected to finish

2010-09-01

Last updated by the study team

2012-06-07

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnostic evidence of mild to moderate Alzheimer's disease.
• CT or MRI results within the past 12 months that rule out dementia due to non-Alzheimer's etiology.
• A reliable and capable caregiver.

You may not qualify if…

• Subjects who reside in a skilled nursing facility.
• Subjects with B12 or folate deficiency.
• Subjects with chronic hepatic disease.
• Subjects with a recent history of hematologic/oncologic disorders.
• Subjects who have experienced a myocardial infarction with the past year.
• Dementia caused or complicated by other organic disease

Where it is running

• Study site — Costa Mesa, California, United States
• Study site — Redlands, California, United States
• Study site — San Diego, California, United States
• Study site — Walnut Creek, California, United States
• Study site — Deerfield Beach, Florida, United States
• Study site — Delray Beach, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Durham, North Carolina, United States
• Study site — Toledo, Ohio, United States
• Study site — Jenkinton, Pennsylvania, United States
• Study site — Wichita Falls, Texas, United States
• Study site — Bennington, Vermont, United States
• Study site — Peterborough, Ontario, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.